Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

TALS Talaris Therapeutics

Watchlist
1.450
+0.010+0.69%
Close 12/02 16:00 ET
1.4500.0000.00%
Post Mkt Price 12/02 16:01 ET
High
1.470
Open
1.420
Turnover
53.16K
Low
1.420
Pre Close
1.440
Volume
36.84K
Market Cap
60.50M
P/E(TTM)
Loss
52wk High
16.630
Shares
41.72M
P/E(Static)
Loss
52wk Low
1.160
Float Cap
18.79M
Bid/Ask %
97.47%
Historical High
19.820
Shs Float
12.96M
Volume Ratio
0.52
Historical Low
1.160
Dividend TTM
--
Div Yield TTM
--
P/B
0.31
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.28%
Amplitude
3.47%
Avg Price
1.443
Lot Size
1
Float Cap
18.79M
Bid/Ask %
97.47%
Historical High
19.820
Shs Float
12.96M
Volume Ratio
0.52
Historical Low
1.160
Dividend TTM
--
P/B
0.31
Dividend LFY
--
Turnover Ratio
0.28%
Amplitude
3.47%
Avg Price
1.443
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Talaris Therapeutics, Inc. engages in cell therapy. It develops methods of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Its technologies are used to treat inherited metabolic enzyme disorders, red blood cell disorders to induce tolerance to organ transplants, and to treat autoimmune disorders such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and scleroderma. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Louisville, KY.
CEO: Mr. Scott Requadt
Market: NASDAQ
Listing Date: 05/07/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist